The Johns Hopkins Gazette: May 3, 1999
May 3, 1999
VOL. 28, NO. 33


Study Shows "Silent" HIV Lasts a Lifetime

Hopkins physicians urge patients to keep taking anti-HIV medication

By Brian Vastag

Johns Hopkins Gazette Online Edition

In 1995, researchers at Johns Hopkins discovered that HIV evades anti-viral drugs by hiding in the immune system, infecting certain white blood cells, called T cells, and then going to sleep, or turning off. In the May Nature Medicine, the same team reports this silent infection persists for a lifetime.

"This doesn't mean a cure for HIV is impossible, but it is an obstacle," says Robert Siliciano (pictured at right), senior author on the report and associate professor of rheumatology and of molecular biology and genetics, School of Medicine. "And it emphasizes that patients need to stay on their medication, possibly for the rest of their lives."

However, not all news from the study was bleak. The study patients, who kept to their strict drug regimens under supervision from physicians at the Johns Hopkins Moore HIV Clinic, all had undetectable levels of HIV in their blood and no signs of AIDS.

"The good news is that patients who comply with their therapy are able to keep the virus suppressed for long periods," says Moore Clinic director Joel Gallant, associate professor of infectious diseases, School of Medicine. "We have assumed that therapy for HIV patients would have to be long-term or even lifelong. This study suggests that is still the case. But the study also suggests that HIV-infected patients can still live long, healthy lives without symptoms provided they are rigorous about taking their medications." When taken as prescribed, combination therapy (the so-called "drug cocktails") of older anti-HIV drugs like AZT and newer protease inhibitors or non-nucleoside reverse transcriptase inhibitors reduces the amount of circulating virus to undetectable levels in most patients. The immune system remains relatively healthy and the collection of diseases that signal AIDS is staved off.

But the latent form of HIV can wait out even decades of anti-HIV therapy. First, it integrates its genetic code into the DNA of dormant, or resting, T cells. While the cells are in their resting phase, the HIV genes inside them remain switched off, a silent infection. When the dormant cells are reactivated, say by a simple infection like the flu, the HIV genes re-emerge, co-opting the cell machinery to make millions of copies of the virus.

Anti-HIV medication suppresses this flood of virus. But without medication to stop it, the virus can replicate out of control, eventually causing AIDS.

"We've seen patients without detectable virus in their blood come off their medication, and within a few weeks or months they experience a rebound, with high levels of virus in their blood," Gallant says. "Now we know that this reservoir of dormant T cells is responsible."

To measure how long the reservoir survives, the team followed 34 patients for two years, periodically drawing blood samples. Using a sophisticated cell-sorting technique developed at Hopkins, they siphoned off the dormant T cells that carried HIV genes and counted them. They found the number of silently infected cells remained stable, or declined very little. A statistical projection showed the reservoir lasting 60 years or more.

Siliciano added that because so few T cells--only one in one million--harbor the silent infection, they are impossible to detect without extremely precise methods. In the Nature Medicine article, the team reports finding the infected T cells in 32 of 34 patients. Since writing the article, they have found silently infected cells in the other two patients.

Diana Finzi, a graduate student in Siliciano's lab, is lead author on the paper and did much of the work isolating the dormant T cells. Researchers from Harvard, Cornell and the National Institute of Allergy and Infectious Diseases contributed to the study. The work was funded by the National Institute of Allergy and Infectious Diseases.

Related Web Sites

Hopkins AIDS Service

Siliciano lab